Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis

BACKGROUND: In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions tow...

Descripción completa

Detalles Bibliográficos
Autores principales: Magele, Astrid, Schoerg, Philipp, Stanek, Barbara, Gradl, Bernhard, Sprinzl, Georg Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746395/
https://www.ncbi.nlm.nih.gov/pubmed/31525208
http://dx.doi.org/10.1371/journal.pone.0221484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746395/
https://www.ncbi.nlm.nih.gov/pubmed/31525208
http://dx.doi.org/10.1371/journal.pone.0221484

Ejemplares similares